Syndax’s leadership in menin inhibition and CSF-1R inhibition – – Revumenib abstracts showcase compelling results in multiple acute leukemia subtypes across the R/R, frontline, and post-HSCT setting – ...

Internal documents show Canada and US partners exploring powers to cancel visitor visas from India and Bangladesh over fraud ...

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious ...

STOCKHOLM, SWEDEN - BTS Group AB (publ), a leading global consultancy specializing in strategy execution, change, and people development, invites investors, analysts and business media to its interim ...

Additionally, the more than 50 abstracts accepted at ASH include new and updated data from Incyte’s MPN, GVHD and hematology programs including interim safety data evaluating axatilimab (Niktimvo™) in ...

The latest update is out from National Bank Holdings ( (NBHC) ).

NIBE Industrier AB ( ($SE:NIBE.B) ) has issued an update. NIBE Industrier AB is set to release its Q3 2025 report on November 14, 2025, and will host a teleconference and webcast presentation for ...

On Friday, November 14, 2025, Kevork Oflazian will present a talk on “Homeland vs. Home: When a Call to Return to the ...

PPT provisions inapplicable in absence of separate notification incorporating MLI provisions into India-Ireland tax treaty Background The Mumbai ITAT in Sky ...

Q3 2025 Earnings Call November 4, 2025 3:00 AM ESTCompany ParticipantsChristina Glenn - Head of Communications and Office of ...

Broad development program assesses ziftomenib across diverse AML segments and treatment paradigms to inform appropriate use - SAN DIEGO and TOKYO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc.

Q3 2025 Sales Call November 4, 2025 3:00 AM ESTCompany ParticipantsDag Skindlo - Chief Executive OfficerEspen Joranger - ...